This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Universal Health (UHS) Q1 Earnings Miss Mark, Tumble Y/Y
by Zacks Equity Research
Universal Health's (UHS) Q1 results reflect a steep expense level and lower admissions in its Behavioral Health Care Services segment, partially offset by revenue recognition.
Tenet Healthcare (THC) Q1 Earnings Beat Mark, Surge Y/Y
by Zacks Equity Research
Tenet Healthcare (THC) Q1 earnings gain from a healthy revenue stream, reduced expenses and operational efficiency.
What to Expect Ahead of HCA Healthcare's (HCA) Q1 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 earnings are likely to reflect gain from better admissions and a higher revenue stream.
UnitedHealth's (UNH) Q1 Earnings Surpass Mark, Improve Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) Q1 results reflect gains from both its segments, Optum and UnitedHealthcare, along with higher revenues.
Zacks Industry Outlook Highlights The Ensign Group, and Brookdale Senior Living
by Zacks Equity Research
The Ensign Group, and Brookdale Senior Living are part of Industry Outlook article.
2 Stocks to Watch From the Promising Nursing Home Industry
by Kaibalya Pravo Dey
The Zacks Medical-Nursing Home industry is set to witness a growing demand from the aging population growth. Ensign Group and Brookdale Senior are poised to benefit from a favorable change in demographics.
Brookdale Senior Living (BKD) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -10% and 0.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 1.04% and 0.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Brookdale Senior Living (BKD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: The Ensign Group and Brookdale Senior Living
by Zacks Equity Research
Zacks Industry Outlook Highlights: The Ensign Group and Brookdale Senior Living
2 Nursing Home Stocks to Brave the Oversupplied Market Woes
by Kaibalya Pravo Dey
Rising costs of equipment and excessive supply pitting downward pressures on occupancy are concerns for the Zacks Medical-Nursing Home industry. However, ENSG and BKD are well-positioned to not only pull through but also grow higher.
Brookdale Senior Living (BKD) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of 38.64% and -1.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Brookdale Senior Living (BKD) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare (HCA) to Acquire Facilities in Utah From Steward
by Zacks Equity Research
HCA Healthcare (HCA) to buy five Utah hospitals from Steward to expand its dominance in the region, and provide cost-effective and enhanced healthcare to patients.
Brookdale Senior Living (BKD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of 6.25% and -3.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Brookdale Senior Living (BKD) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 28th
by Zacks Equity Research
AEVA, BKD, CSGS, DXCM and EIG have been added to the Zacks Rank #5 (Strong Sell) List on July 28, 2021.
HCA Healthcare (HCA) Buys 80% Stake in BHS, Boosts Network
by Zacks Equity Research
HCA Healthcare (HCA) completes purchase of majority stake in Brookdale's BHS, which has added around 80 care sites to the former's portfolio enabling it to offer enhanced healthcare services.
Is Brookdale (BKD) Stock a Solid Choice Right Now?
by Zacks Equity Research
Brookdale (BKD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Brookdale Senior Living (BKD) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -11.32% and -1.93%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Ensign Group, Brookdale Senior Living and Five Star Quality Care
by Zacks Equity Research
Zacks Industry Outlook Highlights: Ensign Group, Brookdale Senior Living and Five Star Quality Care
Cost Woes, Low Occupancy Hit Nursing Home Space: 3 Stocks to Shun
by Zacks Equity Research
The nursing home companies are hit hard by a supply glut in facilities, which is weighing on occupancy levels. Besides, severe competition; expensive labor and heavy investment in technology shoot up the operating costs.
Encompass Health (EHC) Steadily Grows Inpatient Rehab Business
by Zacks Equity Research
Encompass Health (EHC) is continuously investing in post acute care services, which are in huge demand in the United States.
New Strong Sell Stocks for November 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Brookdale Senior Living (BKD) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -70.00% and -3.59%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?